September 7, 2016 – By FINK DENSFORD   Nevro Corp. (NYSE:NVRO) today released 2-year results from Senza-RCT study of its HF10 spinal cord stimulation system, touting superior results over low-frequency SCS therapy treatments. The Redwood City, Calif.-based company said results from the study were published in the journal Neurosurgery. Nevro said the trial is the largest prospective randomized trial […]